Johns Hopkins researchers found that delta-type ionotropic glutamate receptors (GluDs) play a key role in regulating neuronal ...

Scientists at Johns Hopkins have uncovered a surprising new way to influence brain activity by targeting a long-mysterious class of proteins linked to anxiety, schizophrenia, and movement disorders.

Larimar Therapeutics is deeply undervalued, trading at ~$3.40 despite a de-risked safety profile and a clear regulatory path ...

Biohaven has suffered a few setbacks in recent months, including an FDA rejection and a missed $150 million benchmark payment ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

Learn to manage bipolar medication side effects such as weight gain, drowsiness, and brain fog with lifestyle changes and ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

DarioHealth Corp. (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that it has surpassed 100 scientific studies, including peer-reviewed journal ...

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.

Kinder Surprise Eggs – The Chocolate Treat America Can’t Have Kinder Surprise Eggs – The Chocolate Treat America Can’t Have ...

What started as occasional stomachaches and migraines for Valerie Kraft throughout her childhood turned into a decade-long ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...